References
J.P. Bonjour, T. Chevalley, Pubertal timing, bone acquisition, and risk of fracture throughout life. Endocr. Rev. 35, 820–847 (2014)
U. Boehm, P.M. Bouloux, M.T. Dattani, N. de Roux, C. Dodé, L. Dunkel, A.A. Dwyer, P. Giacobini, J.P. Hardelin, A. Juul, M. Maghnie, N. Pitteloud, V. Prevot, T. Raivio, M. Tena-Sempere, R. Quinton, J. Young, Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism-pathogenesis, diagnosis and treatment. Nat. Rev. Endocrinol. 11, 547–564 (2015)
A.A. Dwyer, J. Tiemensma, R. Quinton, N. Pitteloud, D. Morin, Adherence to treatment in men with hypogonadotropic hypogonadism. Clin. Endocrinol. (2016). doi:10.1111/cen.13236
J. Iqbal, H.C. Blair, A. Zallone, L. Sun, M. Zaidi, Further evidence that FSH causes bone loss independently of low estrogen. Endocrine 41, 171–175 (2012)
A. Garcia-Martin, R. Reyes-Garcia, J.M. Garcia-Castro, P. Rozas-Moreno, F. Escobar-Jimenez, M. Munoz-Torres, Role of serum FSH measurement on bone resorption in postmenopausal women. Endocrine 41, 302–308 (2012)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare they have no competing interests.
Ethical approval
All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the Helsinki declaration.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Maione, L., Colao, A. & Young, J. Bone mineral density in older patients with never-treated congenital hypogonadotropic hypogonadism. Endocrine 59, 231–233 (2018). https://doi.org/10.1007/s12020-017-1334-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-017-1334-1